Clinical trials
Renal Insufficiency, Chronic trials in Romania
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 5 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 8 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 6 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 44 |
| Recruiting | 6 |
| Terminated | 6 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 8 |
| Sandoz | 5 |
| Affymax | 4 |
| Anemia Working Group Romania | 4 |
| Astellas Pharma Europe B.V. | 4 |
| Bayer | 4 |
| Eli Lilly and Company | 4 |
| Grigore T. Popa University of Medicine and Pharmacy | 4 |
| GlaxoSmithKline | 3 |
| Lexicon Pharmaceuticals | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Renal Insufficiency, Chronic | 65 |
| Anemia | 21 |
| Kidney Failure, Chronic | 12 |
| Diabetes Mellitus, Type 2 | 10 |
| Cardiovascular Diseases | 3 |
| Hypertension | 3 |
| Kidney Diseases | 3 |
| Atherosclerosis | 2 |
| Diabetic Nephropathies | 2 |
| Heart Diseases | 2 |
Trials
Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.